Twist Bioscience Corp. (TWST)

NASDAQ:
TWST
| Latest update: Nov 4, 2025, 1:29 PM

Stock events for Twist Bioscience Corp. (TWST)

Over the past six months, Twist Bioscience's stock has been influenced by several events, including the release of fiscal Q2 and Q3 2025 earnings reports. Analyst ratings have generally been positive, with a consensus of 'Buy' and an average 12-month price target of $48.56. Insider trading activity has primarily involved sales by company officers. Institutional investors have shown mixed activity, with some increasing their holdings and others decreasing or acquiring new positions. An investor rights law firm has announced an investigation into whether certain officers and directors of Twist Bioscience breached their fiduciary duties.

Demand Seasonality affecting Twist Bioscience Corp.’s stock price

Publicly available information directly detailing the demand seasonality for Twist Bioscience's products and services is not readily available in the provided search results. Specific insights into the seasonal demand patterns for Twist Bioscience's offerings were not found.

Overview of Twist Bioscience Corp.’s business

Twist Bioscience is a synthetic biology company focused on manufacturing and selling synthetic DNA-based products, operating within the Healthcare sector, specifically in the Diagnostics & Research and Biotechnology: Biological Products industries. The company's core business revolves around its silicon-based DNA synthesis platform, enabling high-throughput, cost-effective production of synthetic DNA. Its major products include synthetic genes and gene fragments used in various applications such as therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and academic research. The company also offers Oligo pools for targeted Next-Generation Sequencing (NGS), CRISPR gene editing, and mutagenesis experiments, as well as NGS target enrichment solutions. Furthermore, Twist Bioscience provides immunoglobulin G proteins and antibody libraries for drug discovery and development, and explores DNA as a digital data storage medium.

TWST’s Geographic footprint

Twist Bioscience Corporation is headquartered in South San Francisco, California, and the majority of its revenue is derived from the United States.

TWST Corporate Image Assessment

Within the past year, there have been no specific negative events that have significantly impacted Twist Bioscience's brand reputation. In previous years, the company has been recognized as a 'Great Place to Work-Certified™ company,' one of the 'Most Innovative Biotech Companies,' and listed among the 'Fast 500 Technology Companies.' The ongoing investigation by an investor rights law firm could potentially have reputational implications.

Ownership

Twist Bioscience Corporation's stock ownership is a mix of institutional, retail, and individual investors. Institutional investors hold a significant portion of the company's shares. Major institutional owners include ARK Investment Management LLC, BlackRock Inc., Vanguard Group Inc., Artisan Partners Limited Partnership, William Blair Investment Management, Llc, State Street Corp, EdgePoint Investment Group Inc., and Invesco Ltd. ARK Innovation ETF (ARKK) and ARK Genomic Revolution ETF (ARKG) are also significant holders. Ever Alpha Fund LP is noted as a large individual shareholder. Individual insiders hold approximately 1.69% of the shares.

Expert AI

Show me the sentiment for Twist Bioscience Corp.
What's the latest sentiment for Twist Bioscience Corp.?

Price Chart

$31.57

1.61%
(1 month)

Top Shareholders

ARK Invest LLC
10.73%
BlackRock, Inc.
10.52%
The Vanguard Group, Inc.
9.79%
Artisan Partners Asset Management, Inc.
8.48%
WBC Holdings LP
6.65%
State Street Corp.
4.19%
Edgepoint Investment Group, Inc.
4.00%
Invesco Ltd.
3.94%
Point72 Capital Holdings LP
3.64%
Sumitomo Mitsui Trust Group, Inc.
3.55%
The Goldman Sachs Group, Inc.
2.56%
JPMorgan Chase & Co.
2.41%
UBS Group AG
2.41%
Geode Holdings Trust
2.39%
Baillie Gifford & Co.
2.12%
GFH HFEVA LLC
2.04%
Morgan Stanley
2.01%
First Light Asset Management LLC
1.58%
American Century Cos., Inc.
1.45%
Tao Capital Partners LLC
1.39%

Trade Ideas for TWST

Today

Sentiment for TWST

News
Social

Buzz Talk for TWST

Today

Social Media

FAQ

What is the current stock price of Twist Bioscience Corp.?

As of the latest update, Twist Bioscience Corp.'s stock is trading at $31.57 per share.

What’s happening with Twist Bioscience Corp. stock today?

Today, Twist Bioscience Corp. stock is up by 1.61%, possibly due to news.

What is the market sentiment around Twist Bioscience Corp. stock?

Current sentiment around Twist Bioscience Corp. stock is negative, based on recent news, trading volume, and analyst opinions.

Is Twist Bioscience Corp.'s stock price growing?

Over the past month, Twist Bioscience Corp.'s stock price has increased by 1.61%.

How can I buy Twist Bioscience Corp. stock?

You can buy Twist Bioscience Corp. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol TWST

Who are the major shareholders of Twist Bioscience Corp. stock?

Major shareholders of Twist Bioscience Corp. include institutions such as ARK Invest LLC (10.73%), BlackRock, Inc. (10.52%), The Vanguard Group, Inc. (9.79%) ... , according to the latest filings.